Lionco Pharm Grp Co Ltd (603669) — Capital Reinvestment Ratio
Latest as of September 2023:
0.68x
Lionco Pharm Grp Co Ltd (603669) has a Capital Reinvestment Ratio of 0.68x as of September 2023, meaning it reinvests 1% of its operating cash flow (CN¥7.06 Million) in capital expenditures (CN¥4.78 Million). See Lionco Pharm Grp Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.68x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥7.06 Million
CNY
Capital Expenditures
CN¥4.78 Million
CNY
Data as of
Sep 2023
Most recent filing
Lionco Pharm Grp Co Ltd Capital Reinvestment Ratio (2011–2021)
This chart tracks Lionco Pharm Grp Co Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Lionco Pharm Grp Co Ltd (2011–2021)
Year-by-year Capital Reinvestment Ratio for Lionco Pharm Grp Co Ltd from 2011 to 2021. For live market cap and broader valuation context, see market value of Lionco Pharm Grp Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.43x | CN¥128.50 Million | CN¥54.82 Million | ▼ -12.7% |
| 2020 | 0.49x | CN¥126.81 Million | CN¥61.95 Million | ▲ +959.1% |
| 2019 | 0.05x | CN¥235.61 Million | CN¥10.87 Million | ▼ -95.1% |
| 2018 | 0.93x | CN¥185.87 Million | CN¥173.70 Million | ▲ +104.0% |
| 2017 | 0.46x | CN¥189.01 Million | CN¥86.57 Million | ▼ -6.1% |
| 2016 | 0.49x | CN¥182.27 Million | CN¥88.94 Million | ▼ -31.2% |
| 2015 | 0.71x | CN¥98.88 Million | CN¥70.10 Million | ▲ +10.3% |
| 2014 | 0.64x | CN¥181.50 Million | CN¥116.70 Million | ▼ -0.6% |
| 2013 | 0.65x | CN¥160.77 Million | CN¥103.97 Million | ▼ -15.9% |
| 2012 | 0.77x | CN¥142.61 Million | CN¥109.64 Million | ▲ +205.3% |
| 2011 | 0.25x | CN¥98.23 Million | CN¥24.74 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow